Confident, consistent drug pricing decisions start with a strong foundation

The Medi-Span drug pricing intelligence layer embeds into your workflows to help you enhance your market knowledge to assist with pricing and positioning decisions, to support reimbursement tasks, and to cost-effectively and consistently manage medication-related decisions across the healthcare ecosystem.

To help you make timely decisions, Medi-Span regularly provides new and updated pricing information enabled by our long-standing relationships with pharmaceutical manufacturers. You can also be confident that our pricing benchmark data points and intelligence will always remain as unbiased as possible, as all content is published independently under content and editorial process.

Why is Medi-Span drug pricing intelligence trusted throughout the healthcare industry?

Crucial AWP pricing intelligence embedded in the workflows you use now

Average Whole Price (AWP) is an essential benchmark – widely used throughout the healthcare industry, it provides consistent reference point for billing, reimbursement, contract, and pricing calculations. Medi-Span provides key AWP intelligence that other solutions lack, supporting financial, operational, and treatment decisions throughout the healthcare ecosystem.

The benchmarks you need — from AWP to WAC — from a source you can trust


Medi-Span drug pricing intelligence provides you with a wide variety of pricing concepts, including Average Wholesale Price (AWP) and Wholesale Acquisition Cost (WAC), as well as key reimbursement attributes, so you can more confidently make decisions.

  • Average Wholesale Acquisition Cost Pricing (AWAC)

    Support your pricing analytics with Medi-Span AWAC which provides both AWAC and Generic Equivalent WAC (GEWAC) pricing with current and up to 12 historical prices. We help you by providing a way to determine WAC pricing for a specific NDC when it is unavailable from the manufacturer. You will also receive information necessary to build a WAC-based Price Index for reimbursement rules or payment rules for multiple-source pharmaceutical products.
  • Federal Government Pricing

    • Establish and compare pricing methodologies for state Medicaid and beyond.  
    • Saves you time by eliminating manual processing of pricing updates and data output changes from the government, and by delivering NADAC and/or ACA FUL pricing data in one resource  
    • Helps you stay current with content updates as often as daily when Centers for Medicare and Medicaid Services (CMS) posts new data 
    • Supports a wide range of applications by linking pricing data to National Drug Codes (NDCs) 
    • Assists payers/PBMs in considering price points when establishing contracts, particularly those involving state Medicaid  
    • Helps retail pharmacies anticipate baseline pricing for state Medicaid programs  
  • Medicare Plans

    • Helps save time spent researching and monitoring Medicare reimbursement designations by providing access to Part B and Part D indicators in one consolidated source  
    • Helps reduce tedious manual updates — the file automatically updates with new NDCs and changes in Medicare status as they become available  
  • Medicaid Rebates

    Avoid constant monitoring of Medicaid Rebate Programs.  

    • Helps increase efficiency as you can avoid manual monitoring of the Centers for Medicare and Medicaid Services’ (CMS) website for updates  
    • Saves you time by providing the same information published by the government as part of your regular drug file delivery while helping you with layout changes and non-routine postings by the government  
  • Medi-Span Electronic Drug File (MED-File)

    This foundational drug file provides you with regularly updated codified drug dictionary, drug vocabulary, and drug pricing for prescription drugs and medication-based over-the-counter products in the United States.
  • Payment Allowance Limit – Part B (PAL-B)

    Streamline your medicare reimbursement activities. To support healthcare businesses’ Medicare coverage-related decision-making needs, PAL-B provides consolidated access to timely reimbursement information for drugs covered under Medicare Part B, as published by the Centers for Medicare and Medicaid Services (CMS).

Ready to strengthen your drug pricing foundation?

Talk to a drug pricing intelligence specialist to explore how Medi-Span can support your pricing workflows, help reduce operational burden, and connect you to the timely pricing benchmarks you want and need.

Trusted drug pricing intelligence

Speak to an expert

Please fill out the form and one of our drug pricing specialists will be in touch with you to discuss how Medi-Span drug pricing intelligence can help your organization:

  • Receive frequent updates for trusted drug pricing benchmarks to inform medication management, dispensing, billing, reimbursement and more.
  • Access key benchmarks, including AWP, to support decision-making.
  • Embed pricing intelligence into current workflows, including Epic, to help reduce friction.
Back To Top